Only a tiny minority of members of Congress have known combat, or have family members who have.

NEWYORKER: The Force

Unfortunately, in congressional deliberations to date the risks and costs of not engaging in hostilities to deal with these challenges has received but a tiny fraction of the attention given to speculation about the risks of combat.

CENTERFORSECURITYPOLICY: Center For Security Policy

Tiny biotech AtheroGenics presented new data on its main drug, a pill to combat artery inflammation, that gave some researchers hope the medicine may someday prove effective and make it to market.

FORBES: Magazine Article